5-(N-(2-Chlorophenyl)sulfamoyl)-2-hydroxybenzoic acid

Catalog No.: 
ACKRIC165
CAS No.: 
62547-09-5
Molecular Formula: 
C13H10ClNO5S
Molecular Weight: 
327.74
5-(N-(2-Chlorophenyl)sulfamoyl)-2-hydroxybenzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$100.00InquiryInquiry
250mg95%$236.00InquiryInquiry
1g95%$336.00InquiryInquiry
5g95%$943.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(N-(2-Chlorophenyl)sulfamoyl)-2-hydroxybenzoic acid
IUPAC Name5-(N-(2-chlorophenyl)sulfamoyl)-2-hydroxybenzoic acid
MDL No.MFCD02696653
Molecular FormulaC13H10ClNO5S
Molecular Weight327.74
SMILESO=C(O)C1=CC(S(=O)(NC2=CC=CC=C2Cl)=O)=CC=C1O
InChI KeyVROYVGONLXWDPE-UHFFFAOYSA-N
SynonymZinc03884748;5-[[(2-chlorophenyl)amino]sulfonyl]-2-hydroxyBenzoic acid;Benzoic acid, 5-[[(2-chlorophenyl)amino]sulfonyl]-2-hydroxy-
CAS No.62547-09-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACKRIC165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQXM013 route compound structure diagram
    ACAQXM01317243-13-9In Stock
  4. Then
  5. ACKRIC165 route product structure diagram
    ACKRIC16562547-09-5
Inquiry

2. ACKRIC165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRIC165 route product structure diagram
    ACKRIC16562547-09-5
Inquiry

3. ACKRIC165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRIC165 route product structure diagram
    ACKRIC16562547-09-5
Inquiry

Comments (0)